This is a routine board resignation with no trading signal. Monitor future filings for appointment of a new director, which could indicate board composition changes but is unlikely to affect near-term stock price.
Price Chart
Executive Summary
Director Ian T. Clark resigned from the board of Corvus Pharmaceuticals, effective July 22, 2026, after over nine years of service. No reason was given beyond his notice of intention to resign, and no replacement has been named. This is a routine board-level departure with no immediate impact on operations or strategy.
Key Facts
- Ian T. Clark delivered notice of resignation from the board on July 21, 2026, effective July 22, 2026.
- Clark served on the board for over nine years.
- No replacement director has been named in the filing.
- The company thanked Clark for his contributions; no mention of disagreement or conflict.
Financial Impact
No material financial impact from a single director resignation.
Risk Factors
- Loss of board expertise if Clark's departure leaves a gap in relevant experience, though no immediate risk.
- Potential for additional board departures if internal issues exist, though none indicated.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-085790 |
| Document: 0001104659-26-085790-index-headers.html | 0001104659-26-085790 |
| Document: 0001104659-26-085790-index.html | 0001104659-26-085790 |
| Document: 0001104659-26-085790.txt | 0001104659-26-085790 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 21, 2026 6w ago | Institutional Cluster | $14.46 $12.42 | ▼ −14.11% | ▼ −13.58% | $10.90 (−24.62%) |
Jul 22, 2026 10w ago | 8-K | $13.68 $14.33 | ▲ +4.75% | ▲ +1.44% | $10.90 (−20.32%) |
Jun 11, 2026 16w ago | Institutional Cluster | $11.60 $16.20 | ▲ +39.66% | ▲ +37.76% | $10.90 (−6.03%) |
May 14, 2026 20w ago | 8-K | $13.66 $11.93 | ▼ −12.63% | ▼ −11.77% | $10.90 (−20.18%) |
May 7, 2026 21w ago | 8-K | $15.55 $11.12 | ▼ −28.49% | ▼ −28.51% | $10.90 (−29.90%) |
Apr 24, 2026 23w ago | DEFA14A | $15.92 $12.83 | ▼ −19.41% | ▼ −24.37% | $10.90 (−31.53%) |
Apr 21, 2026 23w ago | Press Release | $17.14 $12.21 | ▼ −28.76% | ▼ −33.68% | $10.90 (−36.41%) |
Mar 12, 2026 29w ago | Press Release | $15.32 $15.17 | ▼ −0.98% | ▼ −4.57% | $10.90 (−28.85%) |
Mar 5, 2026 30w ago | Press Release | $15.80 $14.71 | ▼ −6.87% | ▼ −4.82% | $10.90 (−30.99%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access